VAERS reports by lot

Moderna COVID-19 lot A57144B: VAERS reports

36 VAERS reports list lot A57144B as a Moderna COVID-19 vaccine, received between 2022-09-09 and 2023-07-25. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
36
Reports
11%
Marked serious
0
With a death outcome
7
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)5526%
Cardiac / Cardiovascular3818%
Respiratory3215%
Gastrointestinal2411%
Neurological2110%
Thrombotic / Hematological115%
Dermatological (non-injection-site)115%
Musculoskeletal84%
Allergic / Anaphylactic42%
Psychiatric / Neuropsychiatric31%
Autoimmune / Immune-mediated21%
Injection-site / Local reaction10%

Where reports came from

U.S. state of the reporter, where given (top 12).

Pennsylvania7
New York4
Florida3
Michigan3
California3
New Jersey2
Virginia2
Indiana2
Texas2
District of Columbia1
Maryland1
Iowa1

Reports by month received

2022-099
2022-109
2022-114
2022-125
2023-036
2023-042
2023-071

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.